Baker Ellis Asset Management LLC Sells 690 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Baker Ellis Asset Management LLC decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,196 shares of the company’s stock after selling 690 shares during the period. Baker Ellis Asset Management LLC’s holdings in Henry Schein were worth $3,820,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its stake in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Versant Capital Management Inc lifted its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. City State Bank acquired a new position in Henry Schein in the fourth quarter valued at about $55,000. Farther Finance Advisors LLC lifted its stake in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its stake in Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after buying an additional 1,100 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.8 %

HSIC stock opened at $74.78 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average price of $72.70 and a two-hundred day moving average price of $70.86. The company has a market cap of $9.32 billion, a price-to-earnings ratio of 30.77, a P/E/G ratio of 2.03 and a beta of 0.89. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue was up .4% compared to the same quarter last year. During the same period last year, the company earned $1.32 earnings per share. Analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on HSIC. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Finally, Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Seven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $79.40.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.